Status: current, Defined. Date: 31-Aug 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
448896011000036114 | Sculptra 150 mg powder for injection, 150 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
448897011000036112 | Sculptra (polylactic acid 150 mg) powder for injection, 150 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Sculptra 150 mg powder for injection, 150 mg vial | has intended active ingredient | polylactic acid | true | Inferred relationship | Some | 560300202 | |
Sculptra 150 mg powder for injection, 150 mg vial | has unit of use | vial | true | Inferred relationship | Some | 560300203 | |
Sculptra 150 mg powder for injection, 150 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Sculptra 150 mg powder for injection, 150 mg vial | Is a | Sculptra | true | Inferred relationship | Some | ||
Sculptra 150 mg powder for injection, 150 mg vial | Is a | polylactic acid 150 mg injection, vial | true | Inferred relationship | Some | ||
Sculptra 150 mg powder for injection, 150 mg vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
Sculptra 150 mg powder for injection, 150 mg vial | has Australian BoSS | polylactic acid | true | Inferred relationship | Some | 560300202 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Sculptra 150 mg powder for injection, 1 vial | has TPUU | True | Sculptra 150 mg powder for injection, 150 mg vial | Inferred relationship | Some | 1 |
Sculptra 150 mg powder for injection, 1 vial | has TPUU | True | Sculptra 150 mg powder for injection, 150 mg vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set